NASDAQ · Medical - Devices

PODD (PODD) Stock

$169.70 +2.63% NASDAQ: PODD Healthcare

Valuation

MetricValue
Price$169.70
Market Cap$11.75B
P/E Ratio44.95
P/B Ratio7.15
P/S Ratio3.69
EPS (TTM)$3.48
52-Week High$354.88
52-Week Low$138.97
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE16.30%
ROA7.74%
ROCE31.29%
Gross Margin17.50%
Operating Margin17.50%
Net Margin10.44%
Debt/Equity0.73
Current Ratio2.78

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.1B$1.3B$1.7B$2.1B$2.7B
Operating Profit$126.0M$38.0M$220.0M$309.0M$474.0M
Net Profit$17.0M$5.0M$206.0M$418.0M$247.0M
EPS$0.25$0.07$2.94$5.78$3.48
Op Margin11.5%2.9%13.0%14.9%17.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0B$2.3B$2.6B$3.1B$3.2B
Total Liabilities$1.5B$1.8B$1.9B$1.9B$1.7B
Cash$792.0M$624.0M$651.0M$953.0M$716.0M
Borrowings$1.3B$1.4B$1.4B$1.4B$1.1B

Latest News

3 Quality Compounders on Our Buy List StockStory · Jul 15, 2026 PODD: Lowering target price to $175.00 Argus Research · Jul 15, 2026 Insulet, Calm Form Partnership Targeting Diabetes Community With Wellness Products MT Newswires · Jul 14, 2026 Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss Business Wire · Jul 14, 2026 Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights GlobeNewswire · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-68.0M$119.0M$146.0M$430.0M$569.0M
Investing Cash Flow$-205.0M$-348.0M$-195.0M$-271.0M$-414.0M
Financing Cash Flow$-32.0M$-17.0M$-13.0M$-8.0M$79.0M
Net Cash Flow$-116.0M$-117.0M$15.0M$249.0M$-237.0M
Free Cash Flow$-191.0M$-38.0M$70.0M$305.0M$378.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA19.03
FCF Yield3.85%
Quick Ratio1.81
Interest Coverage5.93
Return 1Y-41.73%
Return 3Y-42.41%
Return 5Y-39.69%

Ownership

Insiders Held0.33%
Institutions Held104.99%
Institutions Float Held105.34%
Institutional HolderSharesReport Date
Blackrock Inc.6,375,9432026-03-31
Vanguard Capital Management LLC4,579,2742026-03-31
FMR, LLC3,974,7122026-03-31
Vanguard Portfolio Management LLC3,449,9872026-03-31
State Street Corporation3,042,4542026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIIBBiogen Inc. $202.30 +0.05% 20.80 $29.87B 0.00%
DGXQuest Diagnostics Incorporated $235.90 +1.75% 21.70 $26.04B 1.68%
DXCMDexCom, Inc. $73.51 +2.75% 26.01 $28.37B 0.00%
LHLabcorp Holdings Inc. $314.14 +4.31% 24.43 $25.76B 1.12%
PHGKoninklijke Philips N.V. $26.59 +0.45% 23.26 $25.99B 3.70%

About PODD

PODD is led by CEO Ashley McEvoy, employs 5,400 people, headquartered in Acton, US, publicly traded since 2007.

PODD stock trades at $169.70 with a market capitalization of $11.75B. The stock is valued at a price-to-earnings (P/E) ratio of 44.95, price-to-book of 7.15, price-to-sales of 3.69. Over the past 52 weeks the stock has ranged between $138.97 and $354.88, and currently trades 52.2% below its 52-week high.

On profitability, PODD generates a return on equity (ROE) of 16.30%, above the typical market average, return on capital employed of 31.29%, an operating margin of 17.50%, a net profit margin of 10.44%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides